Allen Latta's Thoughts on Private Equity, Etc.
  • Allen's Blog
  • Blog Post Categories
  • Glossary of Private Equity Terms
  • Resources
  • About
  • Contact

Understanding The Over-Allotment Option, or Green Shoe, in an IPO

5/23/2012

7 Comments

 
Last week, Facebook priced its initial public offering at $38.00 per share.  Last Friday (May 18), Facebook stock began trading, and the initial trade was at $42.05, a "pop" of over 11%.  However, Facebook's stock price became volatile, and soon fell to the IPO price of $38.  It ended the day at $38.23 per share.  Many press accounts indicated that Morgan Stanley stepped in and purchased shares to stabilize the price.  Some press accounts stated that Morgan Stanley exercised the over-allotment option in the process.  This last statement is incorrect and demonstrates that many people in the press don't fully understand post-IPO price stabilization and the use of the over-allotment option.  This post attempts to shed some light on the matter.

First, and importantly, the IPO price is a sacred thing.  The company, investors and the lead IPO underwriter all want to see the stock trade up in the after-market.  When a stock trades up in the aftermarket, everyone wins.  However, when a stock price falls below the IPO price, the IPO is considered "broken," the company and investors are disappointed and the lead underwriter suffers reputational damage (with the company, with institutions buying the IPO, with future IPO clients, etc.).  In addition, it is common for lawsuits to occur when a stock falls below the IPO price in the first days of trading (see today's news article about the first lawsuits filed in the Facebook IPO).  For these reasons (and more), it is customary for the lead underwriter to work to "stabilize" the market and keep the stock price above the IPO price.  This is called IPO price stabilization and it works due to the existence of a misunderstood tool called the over-allotment option (it's also known as a Green Shoe after the first company to use this mechanism).

As part of the IPO, the company will grant the underwriters an over-allotment option to buy additional shares from the company that can be exercised for up to 30 days after the IPO.  This over-allotment option is typically for a number of shares equal to 15% of the shares offered in the IPO, and has an exercise price equal to the IPO price.  Then, armed with this over-allotment option, the underwriters go and sell the IPO.  But what they really do is sell more shares than are indicated in the prospectus (yes this is legal), and oversell the IPO by 15% (equal to the number of shares covered by the over-allotment option).  Crazy, you say?  Let's look at two scenarios: (1) the stock price goes up; and (2) the stock price goes down.

If the stock price goes up, then the underwriters must deliver those oversold shares.  Since the number of oversold shares equals the number of shares subject to the over-allotment option, all the underwriters do is exercise the over-allotment option and receive the shares from the option to cover the over-selling.  Note that the underwriters don't make a killing by doing this.  They over-sold the offering at the IPO price, and exercised the option at the IPO price, so there's no huge profits made here, (however, the underwriters do get their underwriting fees and commissions on these shares, so they do get an additional 15% commission).

If the stock price goes down, then it's a little more complicated.  As mentioned above, the lead underwriter will support the stock at the IPO price, with a view to not let it "break" the IPO and fall below the IPO price.  The lead underwriter accomplishes this by buying shares back from the market at the IPO price, which helps to stabilize the price and also removes shares from the market (reducing supply).  Because the IPO was oversold, the lead underwriter can buy back these oversold shares at the IPO price with no impact to its balance sheet.  But, once all of the oversold shares are bought back, then if the lead underwriter continues to stabilize and buy shares at the IPO price, its balance sheet is at risk.  If there's a lot of downward pressure on the stock and the lead underwriter has already bought back all of the oversold shares, it will stop stabilizing and the stock price will fall and 'break" the IPO.  This is what happened in the Facebook case.

Let's use an example.  Let's say LattaCo goes public and sells 10 million shares in its IPO at $10 per share, raising $100 million.  As part of the IPO, it grants its underwriters (Acme is the lead underwriter) a 30-day over-allotment option equal to 15% of the IPO shares (1.5 million shares) at the IPO price.  LattaCo and Acme go on the IPO roadshow and Acme starts to build the IPO order book.  While doing so, Acme actually sells 11.5 million shares to buyers at $10 per share.

Once the stock starts trading, the initial trade is $12 per share and the price keeps going steadily up from there, closing its first day of trading at $15 per share and closing at $20 per share a couple days later.  A successful IPO.  But Acme sold 11.5 million shares - how does it make good on those 1.5 million extra shares?  This is where Acme exercises the over-allotment option to obtain those extra shares.  It exercises the option, obtains the 1.5 million shares, delivers the shares, and everyone wins.

But what if the stock doesn't perform well.  Let's assume LattaCo starts trading at $11 per share, but the price starts to drift down to the $10 IPO price.  When the trades get to $10 per share, the lead underwriter Acme will begin to support the stock price by buying shares at $10 per share.  Because the IPO was oversold by 1.5 million shares, Acme can buy back up to 1.5 million shares at $10 per share with no impact to its balance sheet.  In this case, there's no longer any need to exercise the over-allotment option, and after 30 days it will expire.


More depth.  The above is a simplified explanation of the mechanics of price stabilization and the use of the over-allotment option.  We could discuss how the process is like a protected short; we could discuss how the over-allotment option can be from the company and selling shareholders; and we could also discuss the mechanics of how the underwriter actually oversells the IPO by 15% (essentially they borrow the shares from insiders).  But why complicate things?
7 Comments
Truther
6/19/2012 12:26:57 am

Long story short, overallotment is a call option (right to buy at a predetermined "strike" price) on the company's IPO shares for the lead underwriter.

If the IPO stock price goes up, the lead underwriter will exercise the call option and make a profit.

If the IPO stock price goes down, the lead underwriter will allow the call option to expire.

This is a great deal for the lead underwriter considering the call option cost it nothing (i.e. the option's premium is zero).

Reply
Amol
2/24/2015 07:22:28 pm

So far I had read numerous articles by different people on Green shoe Option but undoubtedly this is the best blog on this topic one can ever find. It explains the entire process in such a lucid language that it becomes extremely easy to understand this complicated process. Very well explained !

Reply
Sleuth
10/26/2016 06:24:16 pm

I agreed. Absolutely a well written article.

Reply
Jay
3/25/2015 11:05:03 am

So when the underwriter has to buy back shares they are basically paying off a loan? Is that a reasonable way to think of it?

Reply
Jay
3/25/2015 11:07:26 am

Also, I agree with Amol. This to be by far the best explanation I found. Thanks.

Reply
Mahesh link
6/16/2015 04:40:35 pm

Brilliant write-up! Thank you very much for your lucid explanation :)

Reply
CS N S Zad
2/7/2016 11:15:33 pm

How Green Shoe Option works?
 The company pass resolution in general meeting seeking authorization for the possibility of allotment of further shares to the ‘Stabilizing Agent’ (SA).
 The company appoints Lead Book Runner (or Underwriter) as Stabilizing Agent.
 Stabilizing Agent enters into agreement with the promoter for lending shares. (such lending up to 15% of issue size is permissible) (Assume issue size is 1,00,000 shares plus 15,000 shares borrowed from promoters)
 Total shares equal to ‘issue size’ (i.e. 1,00,000) and shares borrowed from the promoters (i.e. 15,000) will be issued to public. Amount received on extra 15,000 shares from the public will be kept in separate account called escrow account to which SA has access.
 After listing of shares, if the price of shares goes up, the SA is not required to stabilize the price and will exercise the GSO as everyone i.e. company and investor will get benefited. Hence, the company will issue further 15,000 shares to underwriters so that they can return the shares borrowed from the promoters. Total issue in this case will be 1,15,000 shares.
 After listing if price goes down, the SA is required to stabilize the price by buying shares from the market up to 15% i.e. 15,000 shares and these shares will be returned to the promoters. Thus, total issue in this case will be 1,00,000 shares only.

Reply

Your comment will be posted after it is approved.


Leave a Reply.

    About this Blog

    This Blog is a collection of thoughts on a variety of topics of interest to me, including:
    • Private Equity
    • Buyouts
    • Growth Equity
    • Venture Capital
    • Corporate Finance
    • Investment Banking
    • IPOs
    • M&A
    • Technology
    • Economics
    • Law
    I hope you find this blog of interest.
    View my profile on LinkedIn

    Categories

    All
    Anti-Dilution
    Berlin
    Board Of Directors
    Brazil
    Buyouts
    California
    China
    Cleantech
    Corporate Finance
    Corporate Venture Capital
    Crowdfunding
    Dilution
    Dividend Recap
    Economics
    Emerging Managers
    Endowments
    Entrepreneurship
    Europe
    Fund Terms
    General
    Growth Equity
    Healthcare
    India
    Innovation
    Investment Banking
    Ipo
    Israel
    Law
    Legal
    Libor
    Life Sciences
    Listed Private Equity
    London
    Los Angeles
    LP Corner
    M&A
    Mexico
    New York
    Pensions
    Politics
    Private Equity
    Public Stocks
    San Francisco
    Secondaries
    Secondary Exchanges
    Silicon Valley
    South America
    Speaking
    Stock Market
    Stock Options
    Tax
    Technology
    Travel
    United Kingdom
    Valuation
    Venture Capital
    Venture Capital Deal Terms
    Webinars


    Archives

    October 2021
    August 2021
    July 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    February 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    February 2016
    January 2016
    November 2015
    October 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011


    Copyright Notice:

    ​All original works on this site are 
    © 2011-2020 Allen J. Latta. All rights reserved.  Neither this website nor any portion thereof may be reproduced or used in any manner whatsoever
    without the express prior written permission of Allen J. Latta.

    LP Corner® is a registered trademark of Campton Private Equity Advisors.  Used with permission.

    DISCLAIMER:  Readers of this Blog are not to construe it as investment, legal, accounting or tax advice, and it is not intended to provide the basis for the evaluation of any investment.  Readers should consult with their own investment, legal, accounting, tax and other advisors to the determine the benefits and risks of any investment.

    Private equity investments involve significant risks, including the loss of the entire investment.

    This Blog does not constitute an offer to sell or the solicitation of an offer to buy any security.

Copyright © Allen J. Latta.  All rights reserved.